A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT03375164 · COMPLETED
Trial details
- NCT number
- NCT03375164
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-04
- Primary completion
- 2023-04-25
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.